Development and application of new mass spectrometric methods for proteomic analysis, especially of vaccines and biotherapeutic proteins including biosimilar products
Research to determine how modifications to starting materials affect quality attributes of nanomedicines and furthering the development of nanoscale reference materials
Provides cutting-edge capabilities to advance research projects in analytical chemistry and the development of bio-products with commercial applications.